Analyst Patrick Wood from Morgan Stanley maintained a Buy rating on Stryker (SYK – Research Report) and keeping the price target at ...
notably the Mako robotic-arm platform, which revolutionized knee surgeries. A key driver of Stryker's success is its continuous focus on innovation. The Mako system, which combines 3D CT-based ...